Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
10 | 103887337 | intron variant | G/A | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||||
|
0.882 | 0.160 | 10 | 103900115 | missense variant | C/G | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.160 | 10 | 103900115 | missense variant | C/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.160 | 10 | 103900115 | missense variant | C/G | snv |
|
0.800 | 0 | ||||||||||||
|
10 | 103918153 | 5 prime UTR variant | C/A;T | snv | 1.1E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 10 | 103901557 | intron variant | C/A;T | snv |
|
Neoplasms; Nervous System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 103901557 | intron variant | C/A;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.882 | 0.160 | 10 | 103898989 | missense variant | C/A;T | snv | 4.0E-06; 2.4E-05 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 10 | 103898989 | missense variant | C/A;T | snv | 4.0E-06; 2.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 10 | 103898989 | missense variant | C/A;T | snv | 4.0E-06; 2.4E-05 |
|
0.800 | 0 | |||||||||||
|
0.790 | 0.320 | 10 | 103916707 | intron variant | C/A;G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.790 | 0.320 | 10 | 103916707 | intron variant | C/A;G | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.320 | 10 | 103916707 | intron variant | C/A;G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.320 | 10 | 103916707 | intron variant | C/A;G | snv |
|
Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.320 | 10 | 103916707 | intron variant | C/A;G | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.320 | 10 | 103916707 | intron variant | C/A;G | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.320 | 10 | 103916707 | intron variant | C/A;G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
10 | 103894406 | intron variant | A/G | snv | 0.44 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
10 | 103918139 | 5 prime UTR variant | A/C | snv | 0.69 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
10 | 103918139 | 5 prime UTR variant | A/C | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
10 | 103918139 | 5 prime UTR variant | A/C | snv | 0.69 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
10 | 103918139 | 5 prime UTR variant | A/C | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2016 | 2016 |